Seminario web bajo demanda
TARGIT-A: comparación con otros estudios APBI
27 mayo 2021
· 45 MIN VER
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.100.100.0,63,591,654.file/dr-sperk-portrait-2020.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.360.360.0,63,591,654.file/dr-sperk-portrait-2020.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg"})
Autor
Dra. Elena Sperk, doctorado
Profesora asistente, médica sénior jefe y directora de la Unidad de Ensayos Clínicos en el Departamento de Oncología Radiológica, Centro Médico Universitario de Mannheim, Mannheim, Alemania
Resumen
La Dra. Elena Sperk habla sobre el recién publicado estudio a largo plazo TARGIT-A y establece una comparación con otros enfoques APBI
El seminario web clínico grabado empieza con información en profundidad sobre el recién publicado estudio a largo plazo TARGIT-A que se centra en el diseño del ensayo, las características del paciente y los desenlaces clínicos, además de efectos secundarios, un resultado estético y efectos ambientales. En la segunda mitad del seminario web, la Dra. Elena Sperk establece una comparación interesante y relevante con otros enfoques APBI, a la vez que compara aspectos clave como la población de pacientes, los resultados clínicos y las técnicas. El seminario web finaliza con una sesión de preguntas y respuestas.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.100.56.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.360.203.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.768.432.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.1024.576.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.1280.720.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.1440.810.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.1913.1076.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.100.56.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.360.203.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.768.432.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1024.576.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1280.720.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1365.768.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1365.768.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original.image_file.100.56.file/preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original.image_file.360.203.file/preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png"})